Stockreport

Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting

Elicio Therapeutics, Inc.  (ELTX) 
PDF BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipe [Read more]